XML 59 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2013
Schedule of Share-Based Compensation by Expense Category

The following table summarizes the components of share-based compensation expense in the consolidated statements of operations for the three and nine-month periods ended September 30, 2013 and 2012:

 

     Three Months Ended
September 30,
     Nine Months Ended
September 30,
 
     2013      2012      2013      2012  
     (In thousands)  

Research and development

   $ 337       $ 249       $ 876       $ 1,011   

Selling, general and administrative

     903         936         2,380         4,154   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total non-cash compensation expense related to share-based compensation included in operating expense

   $ 1,240       $ 1,185       $ 3,256       $ 5,165   
  

 

 

    

 

 

    

 

 

    

 

 

 
Schedule of Unvested Stock Option Awards

The following table summarizes the activity related to the Company’s restricted stock and RSU’s for the nine-month period ended September 30, 2013:

 

     Number of
Shares
    Weighted-Average
Grant Date
Fair Value
Per Share
 
     (Shares in thousands)  

Unvested at December 31, 2012

     1,830      $ 2.74   

Granted

     642        0.94   

Vested

     (1,003     2.38   

Forfeited

     (276     1.63   
  

 

 

   

 

 

 

Unvested at September 30, 2013

     1,193      $ 2.33   
  

 

 

   

 

 

 
Stock Option
 
Schedule of Weighted-Average Key Assumptions Used in Determining Fair Value of Stock Option Awards

The weighted-average key assumptions used in determining the fair value of stock options granted for the three and nine-month periods ended September 30, 2013 and 2012 were as follows:

 

     Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
     2013      2012     2013     2012  

Weighted-average volatility

     —           100     106.9     96

Weighted-average risk-free interest rate

     —           0.9     0.8     0.9

Weighted-average expected life in years

     —           5.6        4.9        5.5   

Dividend yield

     —           0.0     0.0     0.0

Weighted-average grant date fair value per share

     —         $ 1.38      $ 0.73      $ 1.30   
Schedule of Stock Option Activity

The following table summarizes the activity related to the Company’s stock options for the nine-month period ended September 30, 2013:

 

     Number of
Shares
    Weighted-
Average
Exercise
Price Per Share
     Weighted-
Average
Remaining
Contractual
Term (in yrs)
     Aggregate
Intrinsic
Value of
In-the-Money
Options
 
     (In thousands, except weighted-average data)  

Outstanding at December 31, 2012

     4,027      $ 5.16         7.76       $ 208   

Granted

     1,289        0.95         —           —     

Exercised

     —          —           —           —     

Cancelled

     (953     2.99         —           —     
  

 

 

   

 

 

    

 

 

    

 

 

 

Outstanding at September 30, 2013

   $ 4,363      $ 4.38         7.76       $ 14   
  

 

 

   

 

 

    

 

 

    

 

 

 

Exercisable at September 30, 2013

     2,480      $ 5.56         6.78       $ 9   
  

 

 

   

 

 

    

 

 

    

 

 

 
Stock Options That Contain Performance And Market Based Conditions
 
Schedule of Stock Option Activity

The following table summarizes the activity related to the Company’s performance options for the nine-month period ended September 30, 2013:

 

     Number of
Shares
    Weighted-
Average
Exercise
Price Per Share
     Weighted-
Average
Remaining
Contractual
Term (in yrs)
     Aggregate
Intrinsic
Value of
In-the-Money
Options
 
     (In thousands, except weighted-average data)  

Outstanding at December 31, 2012

     953      $ 3.73         9.30       $ 74   

Granted

     —          —           —           —     

Exercised

     —          —           —           —     

Cancelled

     (420     3.13         —           —     
  

 

 

   

 

 

    

 

 

    

 

 

 

Outstanding at September 30, 2013

     533      $ 4.20         8.52       $ —     
  

 

 

   

 

 

    

 

 

    

 

 

 

Exercisable at September 30, 2013

     358      $ 4.21         8.28       $ —